TVM Capital Healthcare led $ 17 M received by mental health care platform Neurocare
The Munich-based neurocare group AG (neurocare), a pioneer in individualized mental health care that offers tools to enable clinicians to provide the best care possible to their patients, has received a $17 million investment from TVM Capital Healthcare, a specialized healthcare private equity firm with offices in Singapore and Dubai. The investment from TVM Capital Healthcare will help neurocare carry out its plans for international growth, which include entering the Saudi Arabian market and expanding its presence in the US, all while fostering the creation of new hardware and software innovations. In order to increase local access to high-quality healthcare in the MENA region, TVM Capital Healthcare is making its ninth investment.
For a range of neurological and psychological disorders, neurocare offers patient-centered, comprehensive care through its digital therapy platform (DTP). It empowers clinicians and provides individualized care by utilizing cutting-edge mental health care techniques and instruments, such as sleep assessment, therapeutics, psychotherapy, TMS, and neurofeedback, all overseen within a cloud-based solution. After a thorough evaluation of the patient’s state, neurocare assists medical professionals in creating individualized treatment programs that are intended to produce positive, long-lasting clinical results. The company’s own clinics in the US, Europe, and Australia as well as an increasing number of clinics run by third parties use neurocare’s offering.
Mental disorders affect 13.0% of the world’s population (WHO), and they come with enormous direct and indirect costs that are predicted to rise from $2.5 trillion in 2010 to $6 trillion by 2030. Throughout the COVID pandemic, the number of patients receiving a mental health diagnosis doubled. While most nations still have glaring gaps in the treatment of mental health issues, this presents a unique opportunity for companies like neurocare, which provide cutting-edge non-invasive treatments with superior clinical outcomes, as well as a large portion of the population without the support they need.
Tristan de Boysson, Managing Partner, TVM Capital Healthcare, stated: “This investment is part of our strategy of investing in highly innovative, best-in-class healthcare solutions that improve access to quality care across the globe. A special objective of the firm is to improve the healthcare infrastructure in Saudi Arabia and the wider MENA region. Most mental health clinics in this region rely on traditional behavioural and drug care therapy methods, thus creating a first mover advantage for companies like neurocare, which offers innovative mental health treatments with superior clinical outcomes. We are excited about bringing this offering to the people in the MENA region and are looking forward to working together with the neurocare management team to realise this objective.”
Thomas Mechtersheimer, founder and CEO of neurocare group, added: “We are very pleased to announce the cooperation with TVM Capital Healthcare, a strong partner with deep industry experience. This partnership allows us to accelerate neurocare’s growth in our key markets in the US, Europe, and Australia and expand our geographic footprint into new regions. The implementation of our digital therapy platform in clinics in the MENA region represents a new milestone in our company’s growth. I want to thank all involved parties, especially bm-t Thüringen, Aescuvest and Goerg Lawyers, for their advice and support in closing this financing”.
